Abstract:Objective To research the relationship between the plasma levels of myeloperoxidase (MPO) and the onset and progress of acute coronary syndrome (ACS) and the severity of coronary lesions in patients with ACS.Methods Seventy-eight patients hospitalized with chest pain were enrolled,including 41 patients with ACS (ACS group),17 patients with stable angina pectoris (SAP,SAP group) and 20 patients serving as control (control group).Forty-one patients undergoing coronary angiography were divided into single vessel lesions group (7 patients),double vessel lesions group (7 patients),multiple vessel lesions group ( 12 patients) and no vessel lesions group ( 15 patients) based on the vessel lesions of the left anterior descending,left circumflex artery and right coronary artery.According to the diameter stenosis of major coronary artery,there were 15 patients in no vascular stenosis group,2 patients in mild vascular stenosis group,6 patients in moderate vascular stenosis group and 18 patients in severe vascular stenosis group.The levels of MPO were measured by enzyme-linked immunosorbent assays (ELISA).Results The levels of MPO in ACS group [( 252.10 ± 27.07 ) μ g/L]were higher than those in SAP group[( 185.81 ± 17.85 ) μ g/L]and control group [( 140.42 ± 71.40) μ g/L](P ＜ 0.05 ),the levels of MPO in SAP group were higher than those in control group(P＜ 0.05 ).The levels of MPO in single vessel lesions group and multiple vessel lesions group were higher than those in no vessel lesions group (P ＜ 0.05 ),but there was no significant difference among single vessel lesions group,double vessel lesions group and multiple vessel lesions group (P ＞ 0.05 ).The levels of MPO in mild vascular stenosis group,moderate vascular stenosis group and severe vascular stenosis group were higher than those in no vascular stenosis group (P ＜ 0.05),but there was no significant difference among mild vascular stenosis group,moderate vascular stenosis group and severe vascular stenosis group (P ＞ 0.05 ).A positive correlation was observed between the levels of MPO and neutrophils (r =0.288,P=0.018 ),creatine kinase isoenzyme-MB(r =0.469,P=0.043 ),subject groups( r =0.757,P=0.000),vessel lesions (r =0.584,P=0.000) and the degree of vascular stenosis (r =0.491,P=0.001).Conclusion MPO may predict ACS and reflect the severity of coronary lesions in ACS as a novel inflammatory marker.

Clinical Significance of Neutrophil Myeloperoxidase on Peripheral Circulation in Acute Coronary Syndrome

Changes of Neutrophil Myeloperoxidase in Coronary Circulation among Patients with Acute Coronary Syndrome

Correlation Research of Myeloperoxidase and the Severity of Coronary Lesions in Patients with Acute Coronary Syndrome

Early Clinical Screening Value of Myeloperoxidase in Acute Coronary Syndrome

Myeloperoxidase in the Plasma of Patients with Acute Coronary Syndrome

Clinical value of myeloperoxidase in early identification of acute coronary syndrome

Clinical implications of myeloperoxidase in patients with coronary artery disease

[Prognostic Value of Myeloperoxidase Concentration in Patients with Acute Coronary Syndrome].

Relative study on levels of serum myeloperoxidase and IL-6 with severity of coronary artery lesions in acute myocardial infarct

Long-term Prognostic Value of Myeloperoxidase on Acute Coronary Syndrome: a Meta-Analysis.

The Value of Myeloperoxidase Plasma Levels Predict Risk in Patients with Unstable Angina

The expression of myeloperoxidase in thrombi is associated with reduced heme oxygenase-1 induction and worse left ventricular remodeling in patients with acute ST-elevation myocardial infarction

Detection of serum CCL19,CCL21 and MPO in acute coronary syndrome

Correlation Analysis of Plasma Myeloperoxidase Level with Global Registry of Acute Coronary Events Score and Prognosis in Patients with Acute Non-ST-Segment Elevation Myocardial Infarction.

Determination and clinical significance of plasma concentration of monocyte chemoattractant protein-1 in patients with acute coronary syndrome

Myeloperoxidase induces monocyte migration and activation after acute myocardial infarction

Changes of Expression Levels of Peroxisome Proliferator-Activated Receptor-γ and Inflammatory Correlation Factors by Peripheral Blood Monocyte-Derived Macrophages in Patients with Acute Coronary Syndrome

Immune Cell Repertoire And Their Mediators In Patients With Acute Myocardial Infarction Or Stable Angina Pectoris

Characteristic of peripheral blood monocyte subsets and chemokines in early stage of acute coronary syndrome

The Predictive Value of Myeloperoxidase for Contrast-Induced Nephropathy after Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction.

Changes of Platelet Activation Markers and Platelet Ultra-Microstructure in the Patients with Acute Myocardial Infarction